Home / Inspections / 1247270

FDA Inspection 1247270 — Carter BloodCare at Lockheed

Carter BloodCare at Lockheed — FEI 3002965640

The FDA completed an inspection of Carter BloodCare at Lockheed on August 19, 2024 in White Settlement, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 19, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
White Settlement, TX (United States)

Facility

Other inspections at this facility

  • 1079842 (NAI Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1021119 (NAI Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 910023 (NAI Thu Jan 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 802681 (NAI Wed Oct 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 694616 (NAI Sat Oct 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources